Skip to content

A Clinical Study of Vrishadi Ghan Vati and Meshlochnadi Malhar in the Management of Vicharchika (w.s.r) to Eczema

A Clinical Study of Vrishadi Ghan Vati and Meshlochnadi Malhar in the management of Vicharchika ( w.s.r.) to Eczema - Nil

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2024/01/062042
Enrollment
60
Registered
2024-01-30
Start date
Unknown
Completion date
Unknown
Last updated
2024-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L309- Dermatitis, unspecified

Interventions

None listed

Sponsors

Govt.Dhanwantari Ayurvedic College and Hospital Ujjain
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All genders Patient with sign & symptoms of vicharchika like kandu,pidika,vaivarnya,and srava,rajyo,ruja, ruksha. Patient with symptoms of wet eczema &dry eczema.

Exclusion criteria

Exclusion criteria: Patient having skin lesions other than Vicharchika like Psoriasis, Urticaria,Dadru.Pregnancy and Lacting mother.Immuono- compromised patient like Aids( HIV positive), HbsAg positive.Patient having uncontrolled DM/HTN Patient on medication such as steroids, chemotherapy, radiotherapy.Person with sever disorder like Renal, Cardiac problems.

Design outcomes

Primary

MeasureTime frame
To reduce the intensity of classical sign and symptoms of vicharchika like kandu, srava, pidika, ruja ,rajyoTimepoint: To reduce the intensity of classical sign and symptoms of vicharchika like kandu, srava, pidika, ruja ,rajyo

Secondary

MeasureTime frame
Effective management of vicharchika by relieving the symptoms like kandu,srava,pidika,ruja,rajyoTimepoint: After 2 month of study

Countries

India

Contacts

Public ContactDr Vandana saraf

Govt Dhanwantari Ayurvedic Medical College and Hospital Chimanjganj Mandi, ujjain m.p

vandana13ishnavi@gmail.com8085740020

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026